These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 15026314)

  • 1. The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial thromboembolism in patients with systemic lupus erythematosus.
    Brouwer JL; Bijl M; Veeger NJ; Kluin-Nelemans HC; van der Meer J
    Blood; 2004 Jul; 104(1):143-8. PubMed ID: 15026314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects.
    Vayá A; Santaolaria M; Micó L; Calvo J; Oropesa R; Villa P; Todoli J; Simó M; Corella D; Ricart JM
    Clin Hemorheol Microcirc; 2008; 40(2):79-87. PubMed ID: 19029633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired activated protein C resistance is associated with the co-existence of anti-prothrombin antibodies and lupus anticoagulant activity in patients with systemic lupus erythematosus.
    Nojima J; Kuratsune H; Suehisa E; Kawasaki T; Machii T; Kitani T; Iwatani Y; Kanakura Y
    Br J Haematol; 2002 Aug; 118(2):577-83. PubMed ID: 12139749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired activated protein C resistance is associated with lupus anticoagulants and thrombotic events in pediatric patients with systemic lupus erythematosus.
    Male C; Mitchell L; Julian J; Vegh P; Joshua P; Adams M; David M; Andrew ME
    Blood; 2001 Feb; 97(4):844-9. PubMed ID: 11159506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment.
    Salomon O; Steinberg DM; Zivelin A; Gitel S; Dardik R; Rosenberg N; Berliner S; Inbal A; Many A; Lubetsky A; Varon D; Martinowitz U; Seligsohn U
    Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):511-8. PubMed ID: 10073951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies.
    Marchiori A; Mosena L; Prins MH; Prandoni P
    Haematologica; 2007 Aug; 92(8):1107-14. PubMed ID: 17650440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?
    Linnemann B; Schindewolf M; Zgouras D; Erbe M; Jarosch-Preusche M; Lindhoff-Last E
    Thromb Res; 2008; 121(6):743-50. PubMed ID: 17804043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired activated protein C resistance associated with IgG antibodies against beta2-glycoprotein I and prothrombin as a strong risk factor for venous thromboembolism.
    Nojima J; Kuratsune H; Suehisa E; Iwatani Y; Kanakura Y
    Clin Chem; 2005 Mar; 51(3):545-52. PubMed ID: 15637132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies.
    Neville C; Rauch J; Kassis J; Chang ER; Joseph L; Le Comte M; Fortin PR
    Thromb Haemost; 2003 Jul; 90(1):108-15. PubMed ID: 12876633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary upper-extremity deep vein thrombosis: high prevalence of thrombophilic defects.
    Hendler MF; Meschengieser SS; Blanco AN; Alberto MF; Salviú MJ; Gennari L; Lazzari MA
    Am J Hematol; 2004 Aug; 76(4):330-7. PubMed ID: 15282664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of venous thromboembolism in carriers of factor V Leiden with a concomitant inherited thrombophilic defect: a retrospective analysis.
    Meinardi JR; Middeldorp S; de Kam PJ; Koopman MM; van Pampus EC; Hamulyák K; Prins MH; Büller HR; van der Meer J
    Blood Coagul Fibrinolysis; 2001 Dec; 12(8):713-20. PubMed ID: 11734673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of acquired and hereditary risk factors for the development of thromboembolism in patients with systemic lupus erythematosus.
    Gürsoy V; Sadri S; Ermurat S
    Blood Coagul Fibrinolysis; 2023 Dec; 34(8):478-486. PubMed ID: 37756208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombosis risk in systemic lupus erythematosus: the role of thrombophilic risk factors.
    Sallai KK; Nagy E; Bodó I; Mohl A; Gergely P
    Scand J Rheumatol; 2007; 36(3):198-205. PubMed ID: 17657674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Frequency of antiphospholipid antibodies and factor V (G1691A), prothrombin (G20210A) gene polimorphism among women with pregnancy complications].
    Rajewski M; Skrzypczak J
    Pol Arch Med Wewn; 2006 May; 115(5):417-25. PubMed ID: 17195354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antiphospholipid antibodies as risk factor for venous thromboembolism].
    Windyga J
    Pol Arch Med Wewn; 2002 Nov; 108(5):1065-70. PubMed ID: 12685247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME; Cabiedes J; Reyes E; Cabral AR
    Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Leiden, G20210A mutations in prothrombin gene and antiphospholipid antibodies in systemic lupus erythematosus and antiphospholipid syndrome].
    Reshetniak TM; Patrushev LI; Stukacheva EA; Miroshnikov AI; Tikhonova TL; Nasonov EL; Alekberova ZS
    Ter Arkh; 2000; 72(5):34-8. PubMed ID: 11109617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between thrombophilic disorders and type of severe early-onset hypertensive disorder of pregnancy.
    Ganzevoort W; Rep A; De Vries JI; Bonsel GJ; Wolf H;
    Hypertens Pregnancy; 2007; 26(4):433-45. PubMed ID: 18066962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence-based indications for thrombophilia screening.
    Lindhoff-Last E; Luxembourg B
    Vasa; 2008 Feb; 37(1):19-30. PubMed ID: 18512539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between inherited thrombophilias, antiphospholipid antibodies, and lipoprotein A levels and venous thromboembolism in pregnancy.
    Ogunyemi D; Cuellar F; Ku W; Arkel Y
    Am J Perinatol; 2003 Jan; 20(1):17-24. PubMed ID: 12638077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.